These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 26009617)

  • 21. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of human neutrophil peptide-1 as a possible adjunct to antituberculosis chemotherapy.
    Kalita A; Verma I; Khuller GK
    J Infect Dis; 2004 Oct; 190(8):1476-80. PubMed ID: 15378441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental tuberculosis: the role of comparative pathology in the discovery of improved tuberculosis treatment strategies.
    Basaraba RJ
    Tuberculosis (Edinb); 2008 Aug; 88 Suppl 1():S35-47. PubMed ID: 18762152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Influence of various combinations of antitubercular agents on the course of experimental tuberculous infections and development of drug resistance].
    Durisić M; Davidović C; Jovanović M; Marković Lj
    Glas Srp Akad Nauka Med; 1975; (26):17-23. PubMed ID: 816709
    [No Abstract]   [Full Text] [Related]  

  • 25. Review of the Indian market of anti-tuberculosis drugs: focus on the utilisation of rifampicin-based products.
    Catalani E
    Int J Tuberc Lung Dis; 1999 Nov; 3(11 Suppl 3):S289-91; discussion S317-21. PubMed ID: 10593707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing the landscape of tools and approaches for novel tuberculosis regimen development.
    Nuermberger E; Hanna D
    J Infect Dis; 2015 Jun; 211 Suppl 3():S81-2. PubMed ID: 26009616
    [No Abstract]   [Full Text] [Related]  

  • 27. Tuberculosis treatment for the beginning of the next century.
    Schraufnagel DE
    Int J Tuberc Lung Dis; 1999 Aug; 3(8):651-62. PubMed ID: 10460097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antituberculosis drugs: ten years of research.
    Janin YL
    Bioorg Med Chem; 2007 Apr; 15(7):2479-513. PubMed ID: 17291770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Partnerships to Design Novel Regimens to Treat Childhood Tuberculosis, Sui Generis: The Road Ahead.
    Gumbo T; Makhene MK; Seddon JA
    Clin Infect Dis; 2016 Nov; 63(suppl 3):S110-S115. PubMed ID: 27742642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New drugs for the treatment of tuberculosis: hope and reality.
    Grosset JH; Singer TG; Bishai WR
    Int J Tuberc Lung Dis; 2012 Aug; 16(8):1005-14. PubMed ID: 22762423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for promoting fixed-dose combination drugs in tuberculosis treatment and control: a review.
    Monedero I; Caminero JA
    Int J Tuberc Lung Dis; 2011 Apr; 15(4):433-9. PubMed ID: 21396199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacodynamics and pharmacokinetics of domestic fixed-dose combination of antituberculosis drugs].
    Zhao W; Li H; Duan L; Liang G; Zhang T; Lu Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Jun; 25(6):333-6. PubMed ID: 12126555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The early bactericidal activity of antituberculosis drugs.
    Diacon AH; Donald PR
    Expert Rev Anti Infect Ther; 2014 Feb; 12(2):223-37. PubMed ID: 24392698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New drugs for the treatment of tuberculosis: needs, challenges, promise, and prospects for the future.
    Lienhardt C; Raviglione M; Spigelman M; Hafner R; Jaramillo E; Hoelscher M; Zumla A; Gheuens J
    J Infect Dis; 2012 May; 205 Suppl 2():S241-9. PubMed ID: 22448022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bridging the gap in the fight against tuberculosis.
    Davies GR
    Drug Discov Today Technol; 2013 Sep; 10(3):e359-64. PubMed ID: 24050132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antituberculosis drug research: a critical overview.
    Beena ; Rawat DS
    Med Res Rev; 2013 Jul; 33(4):693-764. PubMed ID: 22622957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New drugs for tuberculosis treatment.
    Sánchez F; López Colomés JL; Villarino E; Grosset J
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():47-56. PubMed ID: 21420567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapy of tuberculosis].
    Eier A; Grass S
    Wien Med Wochenschr; 1994; 144(8-9):186-8. PubMed ID: 7941607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical evaluation of new quinolones as antituberculosis drugs].
    Kawahara S; Tada A; Nagare H
    Kekkaku; 1999 Jan; 74(1):71-5. PubMed ID: 10067058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prevalence of primary drug resistance in M. tuberculosis in four administrative areas of the North-Western Federal District of the Russian Federation].
    Baranov AA; Mar'iandyshev AO; Nizovtseva NI; Oparina EN; Presnova SE; Gvozdovskaia LA; Markelov IuM; Trekin IA; Tungusova OS; Mannsoker T
    Probl Tuberk Bolezn Legk; 2006; (12):9-12. PubMed ID: 17300065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.